Analysts are estimating that Agios Pharmaceuticals will report an earnings per share (EPS) of $-1.92.
The announcement from Agios Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings Track Record
Last quarter the company missed EPS by $0.16, which was followed by a 5.96% drop in the share price the next day.
Here's a look at Agios Pharmaceuticals's past performance and the resulting price change:
Quarter
Q2 2025
Q1 2025
Q4 2024
Q3 2024
EPS Estimate
-1.77
-1.76
-1.63
1.11
EPS Actual
-1.93
-1.55
-1.94
-1.43
Price Change %
-6.00
-3.00
0.00
1.00
Market Performance of Agios Pharmaceuticals's Stock
Shares of Agios Pharmaceuticals were trading at $43.43 as of October 28. Over the last 52-week period, shares are down 4.5%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analysts' Perspectives on Agios Pharmaceuticals
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Agios Pharmaceuticals.
Analysts have given Agios Pharmaceuticals a total of 1 ratings, with the consensus rating being ...
